P3 Health Partners Stock Beneish M Score

PIII Stock  USD 0.17  0.01  6.25%   
This module uses fundamental data of P3 Health to approximate the value of its Beneish M Score. P3 Health M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out P3 Health Piotroski F Score and P3 Health Altman Z Score analysis.
  
As of now, P3 Health's Debt To Assets are decreasing as compared to previous years. The P3 Health's current Total Debt To Capitalization is estimated to increase to 1.05, while Short and Long Term Debt Total is projected to decrease to under 85.3 M. As of now, P3 Health's Days Payables Outstanding is decreasing as compared to previous years. The P3 Health's current Income Quality is estimated to increase to 1.24, while PTB Ratio is projected to decrease to 0.96.
At this time, P3 Health's M Score is unavailable. The earnings manipulation may begin if P3 Health's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by P3 Health executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of P3 Health's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.74
Beneish M Score - Unavailable
Elasticity of Receivables

1.0

Focus
Asset Quality

1.08

Focus
Expense Coverage

0.59

Focus
Gross Margin Strengs

0.95

Focus
Accruals Factor

0.59

Focus
Depreciation Resistance

0.92

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

0.71

Focus

P3 Health Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if P3 Health's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables146.7 M139.7 M
Sufficiently Up
Slightly volatile
Total Revenue1.5 B1.5 B
Sufficiently Up
Slightly volatile
Total Assets938.8 M990.1 M
Notably Down
Slightly volatile
Total Current Assets132.7 M190.9 M
Way Down
Slightly volatile
Non Current Assets Total806.1 M799.2 M
Slightly Up
Slightly volatile
Property Plant Equipment14.1 M23.6 M
Way Down
Slightly volatile
Depreciation And Amortization104.7 M99.7 M
Sufficiently Up
Slightly volatile
Selling General Administrative87.6 M140.7 M
Way Down
Slightly volatile
Total Current Liabilities194.7 M344.3 M
Way Down
Slightly volatile
Non Current Liabilities Total91.5 M147.1 M
Way Down
Slightly volatile
Short Term DebtM3.1 M
Fairly Down
Slightly volatile
Long Term Debt75.5 M124.6 M
Way Down
Slightly volatile

P3 Health Partners Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between P3 Health's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards P3 Health in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find P3 Health's degree of accounting gimmicks and manipulations.

About P3 Health Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

104.66 Million

As of now, P3 Health's Depreciation And Amortization is increasing as compared to previous years.

P3 Health Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as P3 Health. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
202020212022202320242025 (projected)
Net Receivables45.6M52.1M79.6M121.5M139.7M146.7M
Total Revenue145.5M485.5M1.0B1.3B1.5B1.5B
Total Assets99.9M2.4B876.6M861.0M990.1M938.8M
Total Current Assets84.3M199.9M100.7M166.0M190.9M132.7M
Net Debt12.9M(50.6M)88.4M85.6M98.5M103.4M
Short Term Debt2.3M3.6M3.6M2.7M3.1M3.0M
Long Term Debt45.4M80M94.4M108.3M124.6M75.5M
Operating Income(39.5M)(35.1M)(1.6B)(167.9M)(151.1M)(158.6M)
Investments(3.9M)(3.2M)(7.7M)(2.0M)(2.3M)(2.4M)
Gross Profit Margin5.02E-41.0(0.0905)0.0250.02870.0273

About P3 Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze P3 Health Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of P3 Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of P3 Health Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out P3 Health Piotroski F Score and P3 Health Altman Z Score analysis.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.87)
Revenue Per Share
11.073
Quarterly Revenue Growth
0.256
Return On Assets
(0.18)
Return On Equity
(0.65)
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.